Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,645 | -31,045 | -21,641 | -13,218 | -8,004 |
| Depreciation Amortization | 68 | 467 | 387 | 286 | 158 |
| Accounts payable and accrued liabilities | 1,807 | 108 | -527 | -621 | -137 |
| Other Working Capital | 3,222 | 1,320 | 1,936 | -794 | 1,007 |
| Other Operating Activity | -497 | 3,463 | 3,086 | 2,244 | 927 |
| Operating Cash Flow | $-6,045 | $-25,688 | $-16,760 | $-12,104 | $-6,049 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,478 | 17,818 | 17,818 | 9,443 | 8,043 |
| Investing Cash Flow | $-16,478 | $17,818 | $17,818 | $9,443 | $8,043 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,202 | -1,571 | -389 | N/A | N/A |
| Common Stock Issued | 9,639 | 81,969 | 80,732 | 80,723 | 18,544 |
| Other Financing Activity | 0 | -3,832 | -3,832 | -3,675 | 0 |
| Financing Cash Flow | $8,436 | $76,566 | $76,511 | $77,047 | $18,544 |
| Beginning Cash Position | 83,061 | 14,284 | 14,284 | 14,284 | 14,284 |
| End Cash Position | 68,975 | 82,981 | 91,853 | 88,670 | 34,822 |
| Net Cash Flow | $-14,086 | $68,697 | $77,569 | $74,386 | $20,538 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,045 | -25,688 | -16,760 | -12,104 | -6,049 |
| Free Cash Flow | -6,045 | -25,688 | -16,760 | -12,104 | -6,049 |